Emily Sutton

573 total citations
15 papers, 298 citations indexed

About

Emily Sutton is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Emily Sutton has authored 15 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 6 papers in Immunology. Recurrent topics in Emily Sutton's work include Systemic Lupus Erythematosus Research (8 papers), Systemic Sclerosis and Related Diseases (6 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Emily Sutton is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Systemic Sclerosis and Related Diseases (6 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Emily Sutton collaborates with scholars based in United Kingdom, Canada and United States. Emily Sutton's co-authors include Ian N Bruce, Julie Davidson, Murray Baron, Janet Pope, Sharon LeClercq, Marie Hudson, Janet Markland, Tariq Iqbal, Richard D. Horniblow and Matthew Bedford and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Cancer Science.

In The Last Decade

Emily Sutton

13 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Sutton United Kingdom 7 194 95 89 68 49 15 298
Weng Giap Law Singapore 11 331 1.7× 180 1.9× 110 1.2× 46 0.7× 32 0.7× 16 429
Risto Perich-Campos Peru 10 248 1.3× 139 1.5× 48 0.5× 41 0.6× 18 0.4× 34 305
DD Gladman Canada 12 290 1.5× 192 2.0× 49 0.6× 57 0.8× 20 0.4× 19 341
Francesca Raffiotta Italy 10 351 1.8× 187 2.0× 42 0.5× 66 1.0× 42 0.9× 15 444
Nicola Tyson United Kingdom 5 131 0.7× 136 1.4× 183 2.1× 33 0.5× 37 0.8× 6 376
Neslihan Yılmaz Türkiye 10 166 0.9× 109 1.1× 86 1.0× 23 0.3× 152 3.1× 30 344
Margaret Michalska United States 9 193 1.0× 89 0.9× 31 0.3× 33 0.5× 47 1.0× 22 291
T Y Lian Singapore 7 396 2.0× 223 2.3× 83 0.9× 64 0.9× 15 0.3× 13 459
Melissa Northcott Australia 9 253 1.3× 272 2.9× 92 1.0× 74 1.1× 18 0.4× 13 457
DP D’Cruz United Kingdom 7 324 1.7× 195 2.1× 33 0.4× 123 1.8× 37 0.8× 9 372

Countries citing papers authored by Emily Sutton

Since Specialization
Citations

This map shows the geographic impact of Emily Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Sutton more than expected).

Fields of papers citing papers by Emily Sutton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Sutton. The network helps show where Emily Sutton may publish in the future.

Co-authorship network of co-authors of Emily Sutton

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Sutton. A scholar is included among the top collaborators of Emily Sutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Sutton. Emily Sutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
4.
5.
Carter, L. M., Adewonuola Alase, Antonios Psarras, et al.. (2022). Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus. Arthritis & Rheumatology. 75(5). 697–710. 14 indexed citations
6.
Sutton, Emily, et al.. (2021). Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR). Lupus Science & Medicine. 8(1). e000513–e000513. 8 indexed citations
7.
8.
Patey, Natalie, Tomoko Takano, Pierre Fiset, et al.. (2019). Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis. Journal of Scleroderma and Related Disorders. 5(2). 152–158. 3 indexed citations
9.
Horniblow, Richard D., Matthew Bedford, Robert M. Hollingworth, et al.. (2017). BRAF mutations are associated with increased iron regulatory protein‐2 expression in colorectal tumorigenesis. Cancer Science. 108(6). 1135–1143. 41 indexed citations
10.
Sutton, Emily, et al.. (2015). A Case of Dengue Hemorrhagic Fever and the Use of Supportive Therapy. The Medicine Forum. 15(1). 1 indexed citations
11.
Sutton, Emily, et al.. (2015). Fever in a Man with HIV: An Unusual Case of an Immune System Gone Wrong. The Medicine Forum. 15(1). 1 indexed citations
12.
Sutton, Emily, et al.. (2014). Tiny Creatures: The World of Microbes. 1 indexed citations
13.
Sutton, Emily, Julie Davidson, & Ian N Bruce. (2013). The Systemic Lupus International Collaborating Clinics (SLICC) damage index: A systematic literature review. Seminars in Arthritis and Rheumatism. 43(3). 352–361. 107 indexed citations
14.
Baron, Murray, Emily Sutton, Marie Hudson, et al.. (2007). The relationship of dyspnoea to function and quality of life in systemic sclerosis. Annals of the Rheumatic Diseases. 67(5). 644–650. 35 indexed citations
15.
Santiago, Mittermayer B., Murray Baron, Kiyomitsu Miyachi, et al.. (2007). A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clinical Rheumatology. 27(1). 77–83. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weng Giap Law Breakdown of academic impact, for papers by Risto Perich-Campos Breakdown of academic impact, for papers by DD Gladman Breakdown of academic impact, for papers by Francesca Raffiotta Breakdown of academic impact, for papers by Nicola Tyson Breakdown of academic impact, for papers by Neslihan Yılmaz Breakdown of academic impact, for papers by Margaret Michalska Breakdown of academic impact, for papers by T Y Lian Breakdown of academic impact, for papers by Melissa Northcott Breakdown of academic impact, for papers by DP D’Cruz
Rankless by CCL
2026